{
    "id": 26624,
    "fullName": "HAVCR1 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "HAVCR1 positive indicates the presence of the HAVCR1 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 26762,
        "geneSymbol": "HAVCR1",
        "terms": [
            "HAVCR1",
            "CD365",
            "HAVCR",
            "HAVCR-1",
            "KIM-1",
            "KIM1",
            "TIM",
            "TIM-1",
            "TIM1",
            "TIMD-1",
            "TIMD1"
        ]
    },
    "variant": "positive",
    "createDate": "05/25/2017",
    "updateDate": "05/25/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11013,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CDX-014 inhibited growth of HAVCR1-positive lung cancer cells in culture, resulted in anti-tumor activity and improved survival in cell line xenograft models (PMID: 27671527).",
            "molecularProfile": {
                "id": 27883,
                "profileName": "HAVCR1 positive"
            },
            "therapy": {
                "id": 5774,
                "therapyName": "CDX-014",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8982,
                    "pubMedId": 27671527,
                    "title": "Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27671527"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11012,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CDX-014 inhibited growth of HAVCR1-positive renal cancer cells in culture, resulted in anti-tumor activity and improved survival in cell line xenograft models (PMID: 27671527).",
            "molecularProfile": {
                "id": 27883,
                "profileName": "HAVCR1 positive"
            },
            "therapy": {
                "id": 5774,
                "therapyName": "CDX-014",
                "synonyms": null
            },
            "indication": {
                "id": 263,
                "name": "kidney cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8982,
                    "pubMedId": 27671527,
                    "title": "Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27671527"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11011,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CDX-014 inhibited growth of HAVCR1-positive ovarian cancer cells in culture, resulted in anti-tumor activity and improved survival in cell line xenograft models (PMID: 27671527).",
            "molecularProfile": {
                "id": 27883,
                "profileName": "HAVCR1 positive"
            },
            "therapy": {
                "id": 5774,
                "therapyName": "CDX-014",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8982,
                    "pubMedId": 27671527,
                    "title": "Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27671527"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27883,
            "profileName": "HAVCR1 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}